Evidence map›Paper›PMID 31218277›Full record

ArticleNon-coding RNA investigation2017

Platelet microparticles: small payloads with profound effects on tumor growth.

David G Menter, Preeti Kanikarla-Marie, Michael Lam, Jennifer S Davis, Scott Kopetz

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Non-coding RNA investigation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

David G MenterDepartments of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Preeti Kanikarla-MarieDepartments of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Michael LamDepartments of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Jennifer S DavisDepartments of Epidemiology, MD Anderson Cancer Center, Houston, TX, USA.
Scott KopetzDepartments of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Center for Clinical and Translational Sciences (CCTS)KL2TR000370 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$4.3M
Platelets promote growth of ovarian cancerR01CA177909 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AFSHAR-KHARGHAN, VAHID, SOOD, ANIL K · 2013 to 2023
$4.1M
Tumor Heterogeneity and Acquired Resistance to EGFR InhibitionR01CA184843 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HAMILTON, STANLEY R., KOPETZ, SCOTT · 2015 to 2019
$3.2M
Therapeutic Strategies for Patients With BRAF Mutant Colorectal CancerR01CA187238 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HONG, DAVID S., KOPETZ, SCOTT · 2014 to 2018
$1.7M
Stress Signaling Pathways and Resistance in Colorectal CancerR01CA172670 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KOPETZ, SCOTT · 2013 to 2017
$1.6M
NCATS NIH HHS KL2 TR000370NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA172670NCI NIH HHS R01 CA177909NCI NIH HHS R01 CA184843NCI NIH HHS R01 CA187238
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31218277
PMCPMC6583804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.